Is Euroapi S.A. (EAPIF) a Buy, Sell, or Hold?
OTC : EAPIF
Euroapi S.A.
$1.51 USD
$0 (0.0%)
- Volume
- 100
- Average Volume
- 65
- Market Capitalization
- $144.31M
- P/E Ratio
- -0.55
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.65
- Year Low
- $1.27
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.60
Company Overview
OTC
David Seignolle
Medical - Devices
Healthcare
EAPIF
3187
FR
USD
Liquidity Metrics
0.08
2.60
0.93
0.39
0.00
Sales & Valuation
$847.88M
0.14
0.15
2.43
0.51
Profitability
-$2.23
-$211.12M
-24.83%
-16.24%
-24.26%
-16.19%
P/E Metrics
-0.55
0.01
0.01
Analyst Price Target & Rating
2/5
1 Analysts
%
Financial Health Scores
0.20
6/9
$473.12M
$1.3B
$516.51M
-$111.3M
Key Metrics (TTM)
$69.15M
0.08
0.49
2.60
-24.26%
-3.40%
-181.28%
41.09%
248 days
Company Executives
| Name | Title |
|---|---|
| Laurence Bollack | Head of Global Media Relations |
| David Seignolle | Chief Executive Officer |
| Frederic Lelievre | Chief Quality Officer |
| Frederic Robert | Chief Commercial Officer |
| Jean-Francois Blanc | Chief Operating Officer |
| Olivier Falut | Chief Financial Officer |
| Marion Santin | Chief Legal, Compliance, & IP Officer |
| Raphaele Hauzy | Chief People Officer |
| Sylvia Cabrillac-Rives | Chief Strategy Officer |
| Sophie Palliez | Head of Investor Relations |
Poll Results
No votes yet today — be the first to share your view!
About Euroapi S.A. (OTC:EAPIF) Stock
Established in 2021 and headquartered in Paris, France, Euroapi SA specializes in the end-to-end process, from development and manufacturing to marketing and distribution, of active pharmaceutical ingredients (APIs) and various intermediary compounds. These essential materials are then utilized in the formulation of a wide array of medicinal products for both human and veterinary applications. ...
EUROAPI statement regarding the Brindisi site
2026-05-13 11:45:00
Press Release Paris – May 13, 2026 – EUROAPI takes note of local media reports regarding its Brindisi site. As previously communicated, the review of strategic options for certain industrial assets is progressing in line with the Group's FOCUS-27 transformation plan, with the objective of completing the related processes by the end of 2027.
Frequently Asked Questions
-
What is the current Euroapi S.A. (EAPIF) stock price?
-
Euroapi S.A.(OTC:EAPIF) stock price is $1.51 in the last trading session. During the trading session, EAPIF stock reached the peak price of $3.65 while $1.27 was the lowest point it dropped to. The percentage change in EAPIF stock occurred in the recent session was 0.0% while the dollar amount for the price change in EAPIF stock was $0.
-
EAPIF's industry and sector of operation?
-
The OTC listed EAPIF is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of EAPIF?
-
Laurence Bollack | Head of Global Media Relations
David Seignolle | Chief Executive Officer
Frederic Lelievre | Chief Quality Officer
Frederic Robert | Chief Commercial Officer
Jean-Francois Blanc | Chief Operating Officer -
How many employees does EAPIF have?
-
Number of EAPIF employees currently stands at 3187. EAPIF operates from 32 rue Alexandre Dumas, Paris, IF 75012, FR.
-
Link for EAPIF official website?
-
Official Website of EAPIF is: https://www.euroapi.com/en
-
How do I contact EAPIF?
-
EAPIF could be contacted at phone #33 1 89 20 62 00 and can also be accessed through its website. EAPIF operates from 32 rue Alexandre Dumas, Paris, IF 75012, FR.
-
How many shares of EAPIF are traded daily?
-
The average number of EAPIF shares traded daily for last 3 months was 65.
-
What is the market cap of EAPIF currently?
-
The market value of EAPIF currently stands at $144.31M with its latest stock price at $1.51